ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,989Medicare Part D Prescriptions Filled, Including Refills

Rank: 45 out of 298

$451K Total Retail Price of All Prescriptions

Rank: 43 out of 298

353 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
44% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Dakota
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 353 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

9% of this provider’s 353 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 8,042 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Dakota
OMEPRAZOLE 338 311 1 3
SIMVASTATIN 336 319 2 2
WARFARIN SODIUM 330 316 3 7
LISINOPRIL 306 267 4 4
METOPROLOL SUCCINATE 299 296 5 12
LEVOTHYROXINE SODIUM 281 261 6 1
BUMETANIDE 254 233 7 71
FUROSEMIDE 246 234 8 5
AMLODIPINE BESYLATE 242 238 9 6
METOPROLOL TARTRATE 242 217 9 9
METFORMIN HCL 191 171 11 10
POTASSIUM CHLORIDE 187 182 12 11
CARVEDILOL 167 165 13 23
CRESTOR 135 135 14 26
ALLOPURINOL 122 121 15 28
DIGOXIN 115 115 16 27
ATORVASTATIN CALCIUM 115 106 16 14
TRAMADOL HCL 115 107 16 15
PREDNISONE 109 90 19 33
TAMSULOSIN HCL 103 103 20 24
HYDROCODONE-ACETAMINOPHEN 98 86 S3 21 8
AGGRENOX 94 94 22 178
LOSARTAN-HYDROCHLOROTHIAZIDE 94 91 22 44
TRIAMTERENE-HCTZ 85 85 24 43
CITALOPRAM HBR 84 61 25 17
DOXAZOSIN MESYLATE 80 67 26 77
ZOLPIDEM TARTRATE 75 48 27 25
LOSARTAN POTASSIUM 73 73 28 18
ALBUTEROL SULFATE 72 54 29 75
ISOSORBIDE MONONITRATE ER 72 72 29 45
LANTUS 69 67 31 53
DONEPEZIL HCL 67 67 32 22
LABETALOL HCL 66 66 33 87
CLOPIDOGREL 59 45 34 36
ATENOLOL 59 59 34 16
SPIRONOLACTONE 58 58 36 34
LISINOPRIL-HYDROCHLOROTHIAZIDE 58 57 36 30
IPRATROPIUM BROMIDE 53 35 38 107
LANTUS SOLOSTAR 53 44 38 93
PLAVIX 52 42 40 70
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 9, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.